Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
ASIA PACIFIC / Science & Health
Mar 23, 2023
China OKs its first mRNA vaccine, from drugmaker CSPC
CSPC Pharmaceutical Group said its independently developed mRNA vaccine targets some major omicron subvariants.
Japan Times
JAPAN / Science & Health
Mar 22, 2023
Hay fever medicine in high demand amid high pollen count
Sales of hay fever-related items such as anti-inflammatory nasal drugs more than doubled to 210% of last year's figure in the week from Feb. 27.
Japan Times
WORLD / Science & Health / FOCUS
Mar 20, 2023
Vaccine-makers prep bird flu shot for humans 'just in case'
One current outbreak of avian flu has killed a record number of birds and infected mammals, but human cases remain rare.
Japan Times
JAPAN
Mar 10, 2023
Japan reports first death directly linked to COVID-19 vaccine
The woman received a Pfizer shot targeting the omicron variant on Nov. 5 at a mass vaccination center.
Japan Times
COMMENTARY / World
Mar 8, 2023
Obesity drugs for kids? Why new guidelines make sense
The American Academy of Pediatrics thinks drugs like Wegovy and Mounjaro could help teens with weight loss.
Japan Times
BUSINESS
Mar 4, 2023
Japanese pharmaceutical firm Takeda lowers price of dengue shot in Brazil and Indonesia
The cost for Qdenga in Indonesia will be about one-third its European price, far lower than many other innovative vaccines, Takeda CEO Christophe Weber said in an interview.
Japan Times
JAPAN / Science & Health
Feb 28, 2023
Japan health ministry panel endorses nasal flu vaccine for children
Based on the results of a clinical trial involving children in Japan, the panel agreed that FluMist Quadrivalent is safe and effective in preventing the flu.
Japan Times
BUSINESS / Companies
Feb 27, 2023
Shionogi sees COVID pill reaping $2 billion in annual sales upon U.S. approval
CEO Isao Teshirogi said he expects U.S. approval of the drug could come by the winter of 2024, pending a late-stage trial.
Japan Times
COMMENTARY / World
Feb 27, 2023
A refreshing gamble on Crispr delivery
Biotech startup Aera is trying to shake up the always-just-out-of-reach field of genetic medicine.
Japan Times
JAPAN / Explainer
Feb 27, 2023
Japan moves toward approving abortion pill in major shift
Currently, surgery is the only option available to terminate a pregnancy in Japan.
Japan Times
JAPAN / Science & Health
Feb 22, 2023
Shionogi says its drug Xocova may reduce risks of long COVID symptoms
For 14 major symptoms of COVID-19, 14.5% of those given Xocova reported at least one of the symptoms six months after the start of treatment, compared with 26.3% who were given a placebo.
Japan Times
COMMENTARY / Japan / Geoeconomic Briefing
Feb 21, 2023
Why pharmaceuticals are a key issue in the ongoing U.S.-China conflict
Beijing has control over the chokepoints — active pharmaceutical ingredients and raw materials — of pharmaceutical supply chains.
Japan Times
JAPAN
Jan 30, 2023
Priority review status given to Alzheimer's drug developed by Eisai and Biogen
The companies said priority review in Japan is granted to new medicines recognized as having high medical utility for serious diseases.
Japan Times
JAPAN / Science & Health
Jan 27, 2023
Abortion pill gets OK from Japan government panel in major step toward final approval
Abortion is legal in Japan up to 22 weeks, but a surgical procedure is currently the only option available for women and consent is usually required from a spouse or partner.
Japan Times
ASIA PACIFIC
Jan 16, 2023
In China, no easy way to get Pfizer's COVID drug Paxlovid
Beijing has acknowledged that supplies are still insufficient to meet demand, even as millions of courses of the treatment were shipped to the country recently.
Japan Times
WORLD / Science & Health
Jan 14, 2023
Pfizer's bivalent vaccine linked to rare strokes in older people in preliminary U.S. data
The early finding still needs more investigation, and recommendations for the vaccine have not been changed, a statement by the U.S. Food and Drug Administration said.
Japan Times
BUSINESS
Jan 13, 2023
Japan's Daiichi Sankyo applies for approval of mRNA COVID vaccine
An approval would give Japan a homegrown mRNA vaccine — a vaccine type that has played a dominant role in the country's COVID-19 inoculation drive to this point.
Japan Times
JAPAN
Jan 11, 2023
Health ministry suggests restricting bulk drug purchases amid hoarding fears
The message follows reports of Chinese people in the country buying medicine in bulk and mailing it to friends and families back home.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?